MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

GSK0660

CAS No. : 1014691-61-2

MCE 站：GSK0660

产品活性：GSK0660是有效的 PPARβ 和 PPARδ 拮抗剂，IC₅₀ 均为155 nM。

研究领域：Cell Cycle/DNA Damage

作用靶点：PPAR

In Vitro: GSK0660 is a potent antagonist of PPARβ and PPARδ, with IC₅₀s of both 155 nM, and is nearly inactive on PPARα and PPARγ with IC₅₀s of both >10 μM. GSK0660 antagonizes 100% of the activity of PPARβ/δ with a pIC₅₀ of 6.8. GSK0660 (100 nM) reduces CPT1a (a PPARβ/δ target gene) expression below the basal vehicle-treated level by approximately 50%, but shows no effect on PDK4 expression, which is also a PPARβ/δ target gene in skeletal muscle cells. GSK0660 (0.5 μM) reduces the levels of AMPK and eNOS phosphorylation, and BMP-2, Runx-2 mRNA expression in MC3T3-E1 cells. GSK0660 (0.1 and 0.5 μM) reverses the bezafibrate-induced enchancement of ALP activity on d 7 in MC3T3-E1 cells. GSK0660 (1 μM) markedly blocks GW501516-mediated attenuation of glutamate release, and the effect of GW501516 on ROS generation in BV-2 cells stimulated with LPS. Furthermore, GSK0660 significantly reduces inhibitory effect of GW501516 on the LPS-induced expression of gp91phox mRNA in BV-2 cells.

相关产品：Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Anti-Aging Compound Library  |  Retinoic acid  |  Rosiglitazone  |  GW9662  |  GW6471  |  Pioglitazone  |  Fenofibrate  |  T0070907  |  Troglitazone  |  Fisetin  |  GW 501516  |  Pirinixic acid  |  5-Aminosalicylic Acid  |  Daidzein  |  GW1929  |  Naringenin  |  Icariin  |  MK-886  |  GW7647  |  Bezafibrate  |  GSK3787  |  GW0742  |  Astaxanthin  |  FH535  |  Magnolol  |  Gemfibrozil  |  Seladelpar sodium salt  |  Palmitelaidic Acid  |  Eupatilin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。